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A B S T R A C T
Rauwolﬁa species (Apocynaceae) are medicinal plants well known worldwide due to its potent bioactive
monoterpene indole alkaloids (MIAs) such as reserpine, ajmalicine, ajmaline, serpentine and yohimbine.
Reserpine, ajmalicine and ajmaline are powerful antihypertensive, tranquilizing agents used in hypertension.
Yohimbine is an aphrodisiac used in dietary supplements. As there is no report on the comparative and
comprehensive phytochemical investigation of the roots of Rauwolﬁa species, we have developed an eﬃcient
and reliable liquid chromatography-tandem mass spectrometry (LC–MS/MS) method for ethanolic root extract
of Rauwolﬁa species to elucidate the fragmentation pathways for dereplication of bioactive MIAs using high-
performance liquid chromatography coupled with electrospray ionization quadrupole time-of-ﬂight tandem
mass spectrometry (HPLC–ESI–QTOF–MS/MS) in positive ion mode. We identiﬁed and established diagnostic
fragment ions and fragmentation pathways using reserpine, ajmalicine, ajmaline, serpentine and yohimbine.
The MS/MS spectra of reserpine, ajmalicine, and ajmaline showed C-ring-cleavage whereas E-ring cleavage was
observed in serpentine via Retro Diels Alder (RDA). A total of 47 bioactive MIAs were identiﬁed and
characterized on the basis of their molecular formula, exact mass measurements and MS/MS analysis.
Reserpine, ajmalicine, ajmaline, serpentine and yohimbine were unambiguously identiﬁed by comparison with
their authentic standards and other 42 MIAs were tentatively identiﬁed and characterized from the roots of
Rauwolﬁa hookeri, Rauwolﬁa micrantha, Rauwolﬁa serpentina, Rauwolﬁa verticillata, Rauwolﬁa tetraphylla
and Rauwolﬁa vomitoria. Application of LC–MS followed by principal component analysis (PCA) has been
successfully used to discriminate among six Rauwolﬁa species.
1. Introduction
Rauwolﬁa species, which belong to Apocynaceae family, are widely
distributed in Asia, Africa and America [1,2]. Apart from the common
Rauwolﬁa serpentina, other species found in India are R. hookeri, R.
micrantha, R. verticillata, R. tetraphylla and R. vomitoria [3].
Rauwolﬁa species have been used for the treatment of hypertension,
snake bites, feverish illnesses and insanity from ancient time in Indian
System of Medicine (ISM), Traditional Chinese Medicine (TCM) and
Western System of Medicine (WSM) [4–6]. The ethanolic extract of the
roots of Rauwolﬁa species has been also used to treat cardiovascular
diseases [7,8], cancer, hypertension [9–12], various psychiatric dis-
eases [1] and snake bites [13]. Dried root powder of Rauwolﬁa
serpentina is also used for the treatment of cancer in Ayurveda [14–
16]. The Rauwolﬁa species are a rich source of bioactive monoterpene
indole alkaloids (MIAs) such as reserpine, ajmaline, ajmalicine,
deserpidine, rescinnamine and yohimbine [17]. Reserpine is a powerful
antihypertensive and tranquilizing agent used for the treatment of
hypertension, schizophrenia, paranoia, breast cancer and Parkinson’s
disease [18–22]. Ajmaline possesses antihypertensive and antiarrhyth-
mic activities and is also used in high blood pressure [23,24].
Ajmalicine is an antihypertensive drug used for treatment of cardio-
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vascular diseases [25]. Serpentine possesses antihistaminase or anti-
histamine activity and is used in the treatment of snake bites [26–28].
Yohimbine has potential clinical applications in erectile dysfunction
and is used as an aphrodisiac in dietary supplements [29,30].
Qualitative and quantitative analyses of MIAs in Rauwolﬁa species
have been carried out using high performance liquid chromatography
(HPLC) [31,32], high performance thin layer chromatography (HPTLC)
[3,33], gas chromatography mass spectrometry (GC–MS) [32], direct
analysis in real time mass spectrometry (DART–MS) [5,34], liquid
chromatography/tandem mass spectrometry (LC–MS/MS) [3,35] and
Orbitrap Velos Pro mass spectrometer [36]. LC–MS/MS oﬀers many
advantages in the analysis of these types of compounds, due to its speed,
sensitivity, speciﬁcity and ability to couple with high performance
chromatographic techniques [37]. There are only a few reports available
for the identiﬁcation and characterization of MIAs by LC–MS/MS in plant
extracts [35,36,38–42]. However, there is no report on the comparative
and comprehensive phytochemical investigation of the roots of Rauwolﬁa
species. Therefore, we have developed a simple and speciﬁc high-
performance liquid chromatography coupled with electrospray ionization
quadrupole time-of-ﬂight tandem mass spectrometry (HPLC–ESI–
QTOF–MS/MS) method to establish fragmentation pathways for the
identiﬁcation and characterization of bioactive compounds from ethanolic
extract of the root of Rauwolﬁa species.
2. Experimental
2.1. Chemicals and materials
LC–MS grade solvents were purchased from Sigma-Aldrich (St.
Louis, MO, USA). Ultra-pure water was produced by Milli-Q Advantage
system (Millipore, USA). AR grade ethanol, purchased from Merck
Millipore (Darmstadt, Germany), was used in the preparation of
ethanolic extracts. Reserpine, ajmalicine, ajmaline and serpentine were
purchased from Sigma-Aldrich (St. Louis, MO, USA) and yohimbine
was purchased from Chem. Faces (Wuhan, Hubei, China).
2.2. Plant materials
The roots of R. hookeri, R. micrantha, R. serpentina, R. tetraphylla,
R. verticillata and R. vomitoria were collected from the plants growing
under similar conditions in Jawaharlal Nehru Tropical Botanic Garden
and Research Institute (JNTBGRI) campus, Kerala, India. The plant
materials were collected in September 2012 and the voucher specimens
(R. hookeri-66449, R. micrantha-66450, R. serpentina-66451, R. tetra-
phylla-66452, R. verticillata-66453 and R. vomitoria-66454) were
deposited in the Herbarium of JNTBGRI. The roots were powdered,
packed in airtight containers and stored at 20 °C until analysis.
2.3. Extraction
The powdered roots (50 g each) were extracted with 250 mL of
ethanol. The extractions were performed by initial sonication for
30 min at 30 °C, followed by being kept at room temperature for
24 h. The extracts were ﬁltered through ﬁlter paper (Whatman no. 1)
and the residues were re-extracted using the same method four times
with fresh solvent at room temperature for 24 h. The combined ﬁltrates
were evaporated to dryness under reduced pressure at 20–50 kPa at
40 °C using a Buchi rotary evaporator. 1 mg/mL stock solutions of each
species of the dried plant extracts were prepared in methanol and
ﬁltered through a 0.22µm polyvinylidene ﬂuoride (PVDF) membrane
into the HPLC auto sampler vial prior to LC–MS analysis.
2.4. HPLC–ESI–QTOF–MS/MS conditions
Analyses were carried out using an Agilent 1200 HPLC system
interfaced with Agilent 6520 hybrid quadrupole time-of-ﬂight mass
spectrometer (Agilent Technologies, USA). The 1200 HPLC system was
equipped with a quaternary pump (G1311A), online vacuum degasser
(G1322A), autosampler (G1329A), thermostatted column compart-
ment (G1316C) and diode-array detector (G1315D).
2.5. Chromatographic conditions
Chromatographic separations were performed using a Thermo
BetaSil C8 column (250 mm×4.5 mm, 5μm) operated at 25 °C employ-
ing a gradient elution using 0.1% formic acid in water (A) and
acetonitrile (B) as mobile phase at a ﬂow rate of 0.6 mL/min. The
elusion consisted of a linear gradient from 25% to 27%; 0–15 min,
27%–37%; 15–18 min, 37%–42%; 18–20 min, 42%–45%; 20–22 min,
45%–48%; 22–25 min, 48–60%; 25–30 min, then returned to the
initial conditions after 5 min. The sample injection volume was 1 μL.
2.6. Mass spectrometric condition
The mass spectrometer was operated in positive electrospray
ionization mode and spectra were recorded by scanning the mass
rangem/z 50–1500 in both MS and MS/MS modes. Nitrogen was used
as drying, nebulising and collision gas. The drying gas ﬂow rate was
12 L/min. The heated capillary temperature was set to 350 °C and
nebulizer pressure at 45 psi. The source parameters capillary voltage
(VCap), fragmentor, skimmer and octapole voltages were set to 3500 V,
175 V, 65 V and 750 V, respectively. For the MS/MS analysis, collision
energy was set at 30 eV and 35 eV, respectively, for reserpine and
ajmalicine classes of compounds whereas 40 eV for ajmaline class of
compounds. The accurate mass data of the molecular ions were
processed through the Mass Hunter Workstation (version B 04.00)
software (Agilent Technology, USA).
2.7. Statistical analysis
HPLC–ESI–QTOF–MS data obtained from three repeats of all the
samples were subjected to statistical analysis. Principal component
analysis (PCA) was performed on statistical software STATISTICA
Version 7.0 (StatSoft, Inc., USA).
3. Results and discussion
3.1. Analysis of standards (templates)
Major bioactive MIAs such as ajmalicine (4), ajmaline (19) serpen-
tine (32), yohimbine (28) and reserpine (44) were selected as templates
to construct the diagnostic fragmentation pathways for identiﬁcation
and characterization of MIAs from plant extracts. Yohimbine and
reserpine showed fragment ions at m/z 323.1560 and 577.2475,
respectively, due to losses of CH3OH. Both compounds also showed
fragment ions at m/z 337.1912 and 397.2108 due to losses of H2O and
C10H12O5, respectively. Fragment ions at m/z 224.1266, 212.1262,
158.0941 and 144.0802 were observed in yohimbine, whereas MS/MS
spectrum of reserpine showed fragment ions at m/z 448.1954,
436.1950, 188.1070 and 174.0916 due to retro Diels Alder (RDA)
cleavage of the C-ring. The fragment ion at m/z 448.1950 from
reserpine gave product ion at m/z 236.1255 due to loss of C10H12O5.
Similarly, the fragment ions at m/z 224.1266 and 212.1262 gave
product ions at m/z 192.1574 and 194.1157 due to losses of CH3OH
and H2O, respectively, in yohimbine (Fig. 1A and B, Scheme 1). The
MS/MS spectrum of ajmalicine showed fragmention ion at m/z
321.1597 due to loss of CH3OH. RDA cleavage produced the fragment
ions at m/z 222.1111, 210.1130, 158.0964 and 144.0784. The product
ion atm/z 190.1114 was formed by loss of CH3OH from the ion at m/z
222.1111 (Fig. 1C and Scheme 2). Successive losses of H2O gave rise to
the ions at m/z 309.1991 and 291.1881 in ajmaline. RDA cleavage of
the C-ring gave characteristic fragment ions at m/z 170.0955,
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158.0958 and 144.0806. The fragment ion at m/z 120.0795 was
produced by loss of H2O from the ion at m/z 138.0911 (Fig. 1D and
Scheme 3). The MS/MS spectrum of serpentine showed fragment ions
at m/z 317.1290 and 263.0789 due to losses of CH3OH and
C4H7OCH3, respectively, whereas fragment ions at m/z 289.1314,
235.0826 and 207.0858 were formed due to successive losses of CO
(Scheme 4).
3.2. Metabolic proﬁling using LC–MS
All the six Rauwolﬁa species were cultivated in similar environ-
mental conditions to study phytochemical variations. Ethanolic extract
of root was analyzed using gradient mobile phase consisting of
acetonitrile and 0.1% aqueous formic acid. Parameters such as column
type, column temperature, mobile phase, elution conditions, ﬂow rate
and MS conditions were optimized. Base peak chromatograms (BPCs)
of ethanolic extracts of R. hookeri, R. micrantha, R. serpentina, R.
tetraphylla, R. verticillata and R. vomitoria in positive-ion mode are
shown in Fig. 2. Retention time (RT), observed [M+H]+, molecular
formula, error (Δppm), major fragment ions and their relative abun-
dance and distribution along with assignment are presented in Table 1.
All these compounds were identiﬁed based on their exact mass,
molecular formula, and fragmentation pattern. A total of 47 known/
unknown MIAs were tentatively identiﬁed and characterized. The
Fig. 1. MS/MS spectra of yohimbine, reserpine, ajmalicine and ajmaline.
Scheme 1. Proposed fragmentation pathways of reserpine class of MIAs.
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proposed structures of the unknown compounds are shown in Fig. 3.
Yohimbine, reserpine, ajmalicine, ajmaline and serpentine were un-
ambiguously identiﬁed and characterized by comparison with their
authentic standards.
3.2.1. Reserpine class of compounds
Seventeen compounds were tentatively identiﬁed and characterized
on the basis of their fragmentation pathways of yohimbine and
reserpine. Compounds 28 and 44 were identiﬁed and characterized
as yohimbine and reserpine, respectively, by comparison with their
authentic standards. Fragmentation pathways of reserpine class of
compounds are shown in Scheme 1. Compounds 1 and 16 were
tentatively identiﬁed as yohimbine acid and reserpic acid, respectively,
which showed characteristic fragment ions at m/z 323.1754 and
383.1965 respectively, due to the losses of H2O whereas fragment
ion at m/z 369.1809 was observed due to loss of CH3OH in compound
16. Compounds 1 (RT 3.4 min) and 11 (RT 6.9 min) gave the same
fragment ions with diﬀerent relative abundances in their MS/MS
spectra. Both compounds 1 and 11 were tentatively identiﬁed as an
isomeric pair. Compounds 16, 18, 27, 29, 38, 40, 41, 43 and 47 were
identiﬁed as 18-hydroxy-yohmbine, reserpic acid methyl ester, sere-
dine, pseudo-reserpine, raunescine, rescidine, deserpidine and rescin-
namine, respectively. Compounds 18, 27, 29, 38, 40, 41, 43 and 47
showed fragment ions at m/z 339.1703, 383.1916, 383.1935,
563.2394, 533.2282, 589.2544, 547.2413 and 603.2779 due to loss
of CH3OH from [M+H]
+ ions, respectively. Similarly, all these com-
pounds also showed fragment ions at m/z 353.1857, 397.2122,
383.1941, 353.1805, 383.1925, 367.2009 and 397.2085, respectively
Scheme 2. Proposed fragmentation pathways of ajmalicine class of MIAs (X: Methyl-14-hydroxy-19-methyl-16,17-didehydro-18-oxayohimban-16 carboxylate).
Scheme 3. Proposed fragmentation pathways of ajmaline class of MIAs.
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due to loss of H2O (compounds 18 and 27), C10H12O5 (compounds 38,
40, 43 and 47) and C12H14O5 (compounds 41 and 47) from [M+H]
+
ions. Fragment ion atm/z 158.0932 was observed in compounds 1, 18,
40 and 43, whereas compounds 16, 27, 38, 40, 41 and 43 showed
fragment ion at m/z 188.1045 due to loss of terpene moiety via C-ring
cleavage followed by bond breaking between C14 and C15. Similarly,
compound 29 gave fragment ion at m/z 218.1178. Compounds 1, 18,
40 and 43 provided RDA fragment ions at m/z 144.0794, whereas
fragment ions at m/z 174.0907 (143 Da+OCH3) was observed in
compounds 16, 27, 38, 41 and 47 due to loss of the terpene moiety
via C-ring cleavage by RDA followed by bond breaking between C3 and
C14. Similarly, the compound 29 showed fragment ion at m/z
204.1029 (142 Da+2OCH3) due to loss of terpene moiety.
Compounds 38, 40 and 43 showed fragment ions at m/z 195.06
whereas fragment ion at m/z 221.0790 was observed in compounds
41 and 47 as base peak. Compounds 27 and 29 may be positional
Scheme 4. Proposed fragmentation pathways of serpentine class of MIAs.
Fig. 2. Base peak chromatograms (BPCs) of ethanolic extracts of Rauwolﬁa species.
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Table 1
Chromatographic and spectrometric characteristics of monoterpene indole alkaloids (MIAs) in ethanolic extracts of six Rauwolﬁa species (root) by high-performance liquid
chromatography coupled with electrospray ionization quadrupole time-of-ﬂight tandem mass spectrometry.
Compound
(peak) no.
RT
(min)
Error
(Δppm)
Obs. m/z Molecular
formula
MS/MS fragment ions (Relative abundance, %) Compounds Distribution
Root
Rh Rm Rs Rt Rv Rvm
Reserpine class
1 3.40 1.49 341.1867 C20H24N2O3 323.1764 (5), 210.1119 (9), 192.1019 (4),
158.0932 (15), 144.0794 (100)
Yohimbinic acid + + + + + +
11 6.95 −0.21 341.1865 C20H24N2O3 323.1762 (3), 210.1153 (11), 192.1018 (5),
158.0953 (15), 144.0797(100),
Yohimbinic acid
(isomer)
+ + + + + +
16 7.81 0.03 401.2071 C22H28N2O5 383.1965 (2), 383.1965 (2), 369.1809 (2),
321.1598 (5), 240.1200 (32), 222.1125 (1),
188.1045 (5), 174.0907 (100)
Reserpic acid + + + + + +
18 8.20 −0.29 371.1966 C21H26N2O4 339.1703 (3), 353.1857 (21), 240.1230 (12),
222.1125 (2), 158.0964 (10), 144.0798 (100),
228.1223 (17)
18-Hydroxy-
yohmbine
+ + + + + +
27 10.75 1.44 415.2217 C23H30N2O5 383.1916 (4), 397.2122 (2), 254.1369 (51),
236.1281 (2), 222.1116 (7), 188.1059 (7),
174.0899 (100), 160.0743 (4)
Reserpic acid
methyl ester
− + − − + −
28 10.91 −0.79 355.2019 C21H26N2O3 323.1560 (10), 224.1285(19), 337.1920 (3),
212.1282 (24), 158.0959 (1), 144.0808 (100)
Yohimbinea + + + + + +
29 11.70 1.44 415.2217 C23H30N2O5 383.1935 (3), 224.1257 (9), 204.1029 (100),
218.1176 (1), 189.0771 (21), 173.0845 (45)
Seredine + + + + + +
38 20.82 −0.49 595.2651 C32H38N2O9 434.1748 (15), 383.1941 (30), 351.1773 (5),
222.1110 (10), 195.0631 (100), 188.10 (3),
174.0880 (43)
Pseudo-
reserpine
+ + + + + +
39 21.20 0.14 563.239 C31H34N2O8 351.1711 (60), 333.1535 (42), 319.1463 (55),
222.1244 (32), 195.0672 (21), 170.0939 (34),
144.0800 (100)
Reserpine class
(unknown)
+ + + + − +
40 21.50 0.19 565.2544 C31H36N2O8 533.2282 (2), 434.1714 (3), 353.1805 (57),
321.1559 (5), 222.1115 (5), 158.063 (2), 195.0622
(100), 144.0777(28),
Raunescine − + + + + +
41 22.90 0.4 621.2805 C34H40N2O9 589.2544 (2), 460.1930 (4), 383.1925 (11),
351.1703 (3), 221.0794 (100), 222.1115 (98),
188.1070 (5), 174.0804 (19)
Rescidine + + + − + +
42 23.48 1.45 591.271 C33H38N2O8 371.1896 (21), 353.1847 (28), 221.0808 (100),
144.0771 (17)
Reserpine class
(unknown)
− − + − − +
43 23.80 0.03 579.2702 C32H38N2O8 547.2413 (12), 367.2009 (79), 448.1907 (1),
335.1730 (24), 236.1262 (10), 195.0649 (100),
144.0817 (38)
Deserpidine + + + − + +
44 24.31 −0.25 609.2807 C33H40N2O9 577.2492 (5), 448.1930 (24), 436.1934 (5),
397.2090 (66), 365.1835 (13), 236.1261 (15),
195.0640 (100), 174.0905 (55)
Reserpinea + + + + − +
45 24.54 1.87 607.2634 C33H38N2O9 367.2017 (17), 335.1765 (11), 236.1272 (7),
221.0820 (100), 206.0577 (10), 190.0621 (14),
144.0815 (35)
Reserpine class
(unknown)
+ + + − − +
46 25.02 1.78 605.2857 C34H40N2O8 369.1805 (20), 221.1805 (100), 206.0598 (11),
190.0618 (27), 174.0910 (40)
Reserpine class
(unknown)
+ + + − − +
47 25.22 0.08 635.2963 C35H42N2O9 603.2779 (1), 474.2066 (5), 397.2085 (22),
236.1281 (2), 221.0791 (100), 188.1070 (2),
174.0881 (11)
Rescinnamine + + + − − +
Ajmalicine class
4 5.52 −0.36 353.1861 C21H24N2O3 321.1598 (1), 222.1124 (1), 210.111 (7), 144.0808
(100), 158.0964 (2)
Ajmalicinaa + + + + + +
6 6.01 0.05 369.1809 C21H24N2O4 337.1558 (19), 222.1275 (16), 351.1703 (37),
291.1496 (5), 158.0963 (30), 144.0808 (100)
Methyl-14-
hydroxy-19-
methyl-16,17-
didehydro-18-
oxayohimban-16
carboxylate
+ + + + + +
24 10.52 1.07 413.2076 C23H28N2O5 397.1763 (3), 323.1560 (3), 222.1106 (28),
218.1176 (18), 204.1005 (100)
Reserpiline + + + + − +
31 14.81 0.02 413.2072 C23H28N2O5 397.1766 (10), 323.1560 (2), 222.1125 (29),
204.1005 (100), 218.1176(30)
Reserpiline
(isomer)
+ + + + + +
33 15.50 0.01 383.1965 C22H26N2O4 351.1677 (2), 222.1110 (10), 159.0675 (3),
188.1053 (2), 174.0895 (100)
10-
Demethoxyre-
serpiline
+ + + + − +
35 17.50 0.23 411.1914 C23H26N2O5 379.1652 (1), 222.1110 (16), 204.1007 (100),
218.1181 (12) 173.0818 (11)
Darcyribeirine − + + + − +
Ajmaline class
2 4.80 0.31 325.1910 C20H24N2O2 307.1715 (5), 186.0896 (12), 174.0913 (57),
160.0805 (100), 146.0935 (22), 138.0954 (12)
Seredamine + + + + + +
S. Kumar et al. Journal of Pharmaceutical Analysis 6 (2016) 363–373
368
isomers distinguished by RDA fragment ions. Compound 27 showed
fragment ions at m/z 174.0899, 188.1059 and 254.1369 whereas
fragment ions atm/z 204.1029, 218.1176 and 224.1257 were observed
in compound 29. Fragments of compounds 27 and 29 showed 30 Da
diﬀerence indicating -OCH3 group on terpene and indole moiety,
respectively (Fig. 4). The characteristic RDA fragment ions at m/z
210.1119 (compounds 1), 240.1200 (compounds 16), 254.1369 (com-
pound 27), 224.1257 (compound 29), 434.1748 (compounds 38 and
40), 460.1930 (compound 41), 448.1907 (compound 43) and 474.2066
(compound 47) were observed due to losses of indole moiety via RDA
cleavage followed by bond cleavage between C2-C3. Fragment ion at
m/z 222.1110 was observed due to loss of H2O (compounds 16),
C10H12O5 (compounds 38 and 40) and C12H14O5 (compound 41) from
fragment ions at m/z 240.1200, 434.1748 and 460.1930, respectively.
Similarly, compounds 27, 29, 43 and 47 showed fragmention at m/z
236.1262 due to loss of H2O (compound 27), C10H12O5 (compound 43)
and C12H14O5 (compound 47) from fragment ions at m/z 254.1369,
448.1907 and 474.2066, respectively. Compounds 39, 42, 45 and 46
may be reserpine class of compounds because all these compounds
followed similar fragmentation pathways with the reserpine and
Table 1 (continued)
Compound
(peak) no.
RT
(min)
Error
(Δppm)
Obs. m/z Molecular
formula
MS/MS fragment ions (Relative abundance, %) Compounds Distribution
Root
Rh Rm Rs Rt Rv Rvm
3 5.01 0.76 311.1752 C19H22N2O2 293.1752 (2), 172.0763 (9), 160.0768 (21),
146.0960 (100), 136.0791 (10)
Hydroxynorte-
traphyllicine
+ + + + + +
8 6.55 1.4 343.2005 C20H27N2O3 325.1927 (8), 307.1830 (15), 186.0906 (54),
174.0917 (60), 160.0766 (22), 138.0912 (100)
Ajmalinol + + + + + +
9 6.60 0.09 313.191 C19H24N2O2 295.1806 (5), 196.1123 (21), 156.0813 (16),
144.0821 (55), 130.0664 (100)
Norajmaline + + + + + +
13 7.45 1.52 503.2386 C26H34N2O3 341.1898 (10), 323.1752 (62), 309.1595 (27),
291.1487 (100)
Hydoxysereda-
mine-O-
hexoside
+ + + + − +
14 7.52 1.26 295.1801 C19H22N2O 277.1666 (4), 156.0799 (7), 144.0811 (27),
138.0474 (47), 130.0656 (100), 120.0791 (24)
Nortetraphylli-
cine
+ + + + + +
19 8.91 0.13 327.2067 C20H26N2O2 309.1991 (3), 291.1839 (3), 170.0974 (45),
158.0964 (100), 144.0812 (82)
Ajmalinea + + + + + +
21 9.53 0.6 309.196 C20H24N2O 291.1780 (4), 263.1536 (31), 170.0950 (19),
158.0965 (77), 144.0817 (100), 120.0822
Tetraphyllicine − + + + − −
22 9.84 1.4 353.186 C21H24N2O3 335.1758 (3), 275.1501 (2), 156.0808 (4),
144.0890 (100), 130.0693 (7)
Quebrachidine + + + + + +
23 10.11 0.11 355.2017 C21H26N2O3 309.2031 (5), 277.1667 (13), 260.1360 (12),
170.0955 (78), 158.0956 (98), 144.0805 (78)
Hydroxymethyl-
seredamine
+ + + + + +
36 19.31 0.28 351.2066 C22H26N2O2 291.1827 (17),182.962 (78), 170.0956 (45),
158.0962 (45), 144.0803 (100), 120.0802 (10)
17-O-
Acetyltetraphyl-
licine
+ − + + − −
37 20.76 0.45 489.2595 C26H36N2O7 327.2073 (100), 309.1663 (80), 291.1554 (47) Ajmaline-O-
hexoside
+ + − +
Quaternary alkaloids
15 7.70 1.25 513.2232 C27H32N2O8 333.1615 (14), 274.1199 (16), 246.1299 (53),
230.0986 (87), 220.1137 (67), 204.0823 (100),
195.0926 (65),
Tetradehydroyo-
himbine-O-
hexoside
+ + + + + +
20 9.17 0.25 511.2373 C37H30N2O8 349.1548 (100), 317.1326 (24), 289.1313 (10) Serpentine-O-
hexoside
+ + + + + +
25 10.60 0.85 335.1389 C20H18N2O3 317.1296 (100), 289.1492 (7), 263.0808 (71),
235.0863 (34), 307.0858 (5)
Serpentine
derivative
− + + + + +
26 10.70 −1.54 351.1707 C21H22N2O3 351.1674 (100), 333.1570 (4), 219.1440 (5),
271.1470 (20), 248.1024 (4), 195.0890 (6),
168.0788 (13)
Tetradehydroyo-
himbine
+ + + + + +
32 15.40 0.47 349.1547 C21H20N2O3 317.1290 (66), 289.1314 (7), 263.0796 (100),
235.0826 (34), 307.0858 (6)
Serpentinea + + + + − +
34 16.62 0.45 685.3375 C42H45N4O5 653.3131 (13), 435.1947 (23), 403.1516 (3),
349.1235 (2), 375.1701 (23), 251.1558 (7)
Serpentinine + + + − − −
Other compounds
5 5.93 1.47 343.2015 C20H26N2O3 326.1972 (47), 307.1794 (16), 182.0968 (57),
170.0945 (36), 158.0962 (81), 144.0795 (100),
132.0757 (11)
Rauvotetraphyl-
line A
+ + + + + +
7 6.33 1.25 313.1917 C19H24N2O2 295.1845 (7), 144.0819 (70), 138.0933 (100),
122.0869 (61)
Dihydroperak-
sine
+ + + + + +
10 6.90 0.89 311.1755 C19H22N2O2 293.1641 (8), 156.0808 (17), 144.0804 (52),
138.0919 (10), 130.0650 (100), 120.0805 (28)
Norajmalidine − + + + − −
12 7.12 0.12 513.2231 C27H32N2O8 351.1994 (100), 291.1480 (16) Raucaffricine + − + + + +
17 8.02 0.15 309.1598 C19H20N2O2 291.1492, 172.0782 (24), 160.0757 (51),
146.0612 (100), 172.0782 (24), 136.0780 (38),
120.0803(15)
Normitoridine + + + + + +
30 12.04 0.74 429.2018 C23H28N2O6 397.1781 (87), 369.1759 (10), 339.1340 (14),
220.0972 (100), 210.1124 (35), 205.0732 (9),
189.0772 (21), 178.0845 (13), 150.0913 (21)
Carapanaubine + + + − + +
a Matched with the standards. Rh:R. hookeri; Rm: R. micrantha; Rs: R. serpentina; Rt: R. tetraphylla; Rv: R. verticillata; Rvm: R. vomitoria. RT: Retention time; Obs: observed.
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provided the characteristic fragment ions (Fig. 3).
3.2.2. Ajmalicine class of compounds
Six compounds 4, 6, 24, 31, 33 and 35 were identiﬁed and
characterized as ajmalicine, methyl-14-hydroxy-19-methyl-16,17-dide-
hydro-18-oxayohimban-16 carboxylate, reserpiline, reserpiline (iso-
mer), 10-demethoxyreserpiline and darcyribeirine, respectively
(Scheme 2). Compound 4 was identiﬁed and characterized by compar-
ison with the authentic standard of ajmalicine. Compounds 6, 24, 33
and 35 showed fragment ions at m/z 337.1558, 323.1560, 351.1677
and 379.1652 due to loss of CH3OH, respectively. Fragment ions at m/
z 158.0963 (compound 6), 218.1174 (compounds 24 and 35) and
188.1053 (compound 33) were observed due to loss of terpene
moiety via RDA cleavage followed by bond cleavage between
C14 and C15. Similarly, the fragment ions atm/z 144.0808 (compound
6), 174.0895 (143 Da+OCH3) (compound 33) and 204.1005 (142 Da
+2OCH3) (compounds 24 and 35) were observed as base peak
due to loss of terpene moiety via RDA followed by bond cleavage
between C3 and C14. Compounds 24 and 31 may be isomeric pair,
showing similar fragment at retention time 10.52 min and 14.81 min
with diﬀerent relative abundances of fragment ions. RDA fragment ion
at m/z 222.1124 was observed in all compounds due to loss
of indole moiety via RDA cleavage followed by bond cleavage between
C2 and C3.
3.2.3. Ajmaline class of compounds
Twelve ajmaline class of compounds 2, 3, 8, 9, 13, 14, 19, 21, 22,
23, 36 and 37 were tentatively identiﬁed and characterized as
seredamine, hydroxynortetraphyllicine, ajmalinol, norajmaline, hydox-
yseredamine-O-hexoside, nortetraphyllicine, ajmaline, tetraphyllicine,
quebrachidine, hydroxymethylseredamine, 17-O-acetyltetraphyllicine
and ajmaline-O-hexoside, respectively (Scheme 3). Compound 19 was
identiﬁed and characterized by comparison with ajmaline standard.
Compounds 2, 3, 8, 9, 14, 21, 22, 23 and 36 showed fragment ions at
m/z 307.1715, 293.1752, 325.1927, 295.1806, 277.1666, 291.1780,
335.1758, 309.2031 and 291.1827 due to loss of H2O except com-
pound 36 (-CH3COOH). Fragment ions at m/z 186.0896 [155 Da
+OMe] (compound 2), 172.0763 [155 Da+OH] (compound 3 and 8),
156.0813 (compounds 9, 14 and 22) and 170.0974 [155 Da+CH3]
(compounds 21, 23, and 36) were observed due to loss of terpene
moiety via RDA cleavage followed by bond cleavage between C14 and
C15. Similarly, fragment ions at m/z 174.0913 [143 Da+OMe] (com-
pound 2), 160.0768 [143 Da+OH] (compounds 3 and 8), 144.0821
(compounds 9, 14, and 22) and 158.09 [143 Da+CH3] (compounds 21,
23 and 36) formed due to loss of terpene moiety via RDA cleavage
followed by bond cleavage between C3 and C14. All compounds showed
RDA fragment ions atm/z 160.0805 [129 Da+OMe] (compounds 2 and
8), 146.0960 (129 Da+OH) (compound 3), 130.0656 (compounds 9, 14
and 22) and 144.0817 [129 Da+CH3] (compounds 21, 23 and 36) due
to loss of terpene moiety via RDA cleavage followed by bond cleavage
between C2 and C3. Compounds 13 and 37 were identiﬁed as
hydoxyseredamine-O-hexoside and ajmaline-O-hexoside which showed
a characteristic loss of 162 Da and gave fragment ions atm/z 341.1898
and 327.2073, respectively.
Fig. 4. Structures of isomeric compounds.
Fig. 3. Structures of unknown and other class of compounds.
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3.2.4. Quaternary indole alkaloids
Six quaternary indole alkaloids compounds 15, 20, 25, 26, 32 and
34 were identiﬁed and characterized as tetradehydroyohimbine-O-
hexoside, serpentine-O-hexoside, serpentine derivative, tetradehy-
droyohimbine, serpentine and serpentinine. Compound 32 was identi-
ﬁed and characterized as serpentine which also matched with the
standard. Compound 15 was identiﬁed as a hexoside of tetradehy-
droyohimbine and it showed fragment ion at m/z 351.1674 due to the
Scheme 5. Proposed fragmentation pathways of serpentinine.
Scheme 6. Proposed fragmentation pathways of carapanaubine.
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loss of C6H10O5. Fragment ion at m/z 351.1674 gave product ions at
m/z 333.1615 and 319.1440 due to further losses of H2O and CH3OH,
respectively. Compound 20 showed fragment ion at m/z 349.1548 due
to characteristic loss of 162 Da (C6H10O5). Compound 25 was identi-
ﬁed as serpentine derivative which showed 15 Da lower molecular
weight compared to serpentine and followed similar fragmentation
pattern. It showed fragment ions atm/z 317.1296 and 289.1492 due to
losses of H2O and CO, respectively. Compound 34 showed fragment
ions atm/z 653.3131, 435.1956 and 251.1546 due to losses of CH3OH,
C25H26N2O5 and C17H18N2, respectively. Fragment ion m/z 435.1956
showed product ions at m/z 375.1732, 349.1235, and 403.1516 due to
losses of C2H4O2, C4H6O2 and CH3OH, respectively (Scheme 5).
3.2.5. Other indole alkaloids
Six indole alkaloids 5, 7, 10, 12, 17 and 30 were tentatively
identiﬁed and characterized as rauvotetraphylline A, dihydroperaksine,
norajmalidine, raucaﬀricine, normitoridine, and carapanaubine, re-
spectively. Compounds 5, 7, 10 and 17 showed fragment ions at m/z
326.1972, 295.1845, 293.1641 and 291.1492, respectively due to loss
of H2O from precursor. The RDA fragment ions at m/z 158.0962
[143+CH3], 144.0795, 156.0808 and 172.0782 were observed in
compounds 5, 7, 10 and 17 due to C-ring cleavage via RDA.
Similarly, RDA fragment ions at m/z 130.0650 and 146.0612
[129+OH] were observed as base peaks in compounds 10 and 17,
respectively. Compound 12 showed fragment ions atm/z 351.1994 and
291.1480 due to losses of C6H10O5 and C2H4O2, respectively.
Compound 30 showed fragment ions at m/z 397.1781, 369.1759,
353.1501 and 339.1340 due to successive losses of CH3OH, CO, CH4
and CH3, respectively. Fragment ions at m/z 210.1124 and 220.0972
were observed as base peaks due to C-ring cleavage. Further fragment
ions at m/z 210.1124 and 220.0972 produced fragment ions at m/z
178.0845 and 205.0732 due to losses of CH3OH and CO, respectively.
Fragment ions at m/z 150.0913 and 189.0772 formed due to
losses of CO and CH4 from m/z 178.0845 and 205.0732, respectively
(Scheme 6).
3.3. Identiﬁcation of markers using PCA
PCA converts a large number of data sets to a smaller number of
variables. It produces overall discrimination between the closely
related samples for quality control and authentication [43–45]. LC–
MS data in combination with a data reduction technique such as PCA
serves as an eﬃcient and powerful tool to identify the chemical markers
[34,43,44]. The LC–MS chemical ﬁngerprints of R. hookeri, R.
micrantha, R. serpentina, R. tetraphylla, R. verticillata, and R.
vomitoria roots were analyzed by PCA to identify the chemical markers
for discrimination amongst these species.
A total of 66 peaks from mass range m/z 179.0708 to 635.2984,
peak area ≥1000, were taken from the HPLC–ESI–QTOF–MS ﬁnger-
prints (n=3) of roots and PCA was run. The PC1 and PC2 together were
able to explain 57.96% of variance information. To obtain the best
expression, peaks with lowest contribution were dropped and only
twelve peaks at m/z 323.2134 (unknown), 325.1910 (seredamine),
343.2005 (ajmalinol), 327.2067 (ajmaline), 327.2104 (isomer of ajma-
line), 355.2019 (yohimbine), 355.2029 (isomer of yohimbine),
349.1547 (serpentine), 383.1965 (10-demethoxyreserpiline),
351.1707 (tetradehydroyohimbine), 413.2067 (reserpiline) and
621.2805 (rescidine) were identiﬁed as marker peaks which were
responsible for discrimination of six Rauwolﬁa species. Using these
chemical markers PCs could explain 80.03% of the variance informa-
tion as shown in the score and loading plots (Fig. 5). Peak at m/z
343.2005 (46.55%) showed a higher contribution followed by m/z
327.2104 (33.47%) and 327.2067 (12.28%), respectively. Similar
report with contribution of peak area has already been reported in
chromatographic ﬁngerprinting and quantitative analysis of Xinkeshu
tablet [46]. The PCA plots aﬀorded useful qualitative information of six
Rauwolﬁa species roots and revealed similarities and dissimilarity
among them shown in Fig. 5A. It showed that R. serpentina. R.
micrantha and R. verticillata were close whereas R. hookeri, R.
tetraphylla, R. vomitoria were much apart from each other. R.
serpentina is commonly used in herbal formulations and endangered
due to over-exploitation [47]. This study showed that R. micrantha and
R. verticillata might be used as substitutes for R. serpentina in herbal
formulations. Hence, this analysis will also help to use alternate plant
on the basis of phytochemical investigation which may conserve the R.
serpentina.
4. Conclusions
A simple, sensitive, reproducible HPLC–ESI–QTOF–MS/MS meth-
od was developed in positive ion mode for the dereplication of MIAs.
The diagnostic fragmentation pathways were established with the help
of MS/MS spectra or diagnostic fragment ions of standard compounds.
Reserpine, ajmalicine, ajmaline and yohimbine classes of MIAs showed
two types of fragment ions, namely due to loss of substituents which
were attached with the terpene moiety and RDA fragment ions. The
established diagnostic fragmentation pathways were applied for iden-
tiﬁcation and characterization of MIAs. 47 compounds were tentatively
identiﬁed and characterized in ethanolic extract of roots of R. hookeri,
R. micrantha, R. serpentina, R. tetraphylla, R. verticillata and R.
vomitoria. Hydoxyseredamine-O-hexoside (13), ajmaline-O-hexoside
(37), tetradehydroyohimbine-O-hexoside (15), serpentine-O-hexoside
(25) and 4 reserpine class compounds 39, 42, 45 and 46 were identiﬁed
as unknown/new for the ﬁrst time. The isomeric compounds reserpic
Fig. 5. (A) PCA score plot from Rauwolﬁa species showing discrimination among the R. hookeri, R. micrantha, R. serpentina, R. tetraphylla, R. verticillata and R. vomitoria. (B)
Loading plot of the normalized LC–MS data obtained from three samples of each species showing possible ions of interest including those predominantly responsible for the
discrimination of R. hookeri, R. micrantha, R. serpentina, R. tetraphylla, R. verticillata and R. vomitoria.
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acid methyl ester (27) and seredine (29) were successfully distin-
guished by MS/MS analysis. The marker peaks were successfully
identiﬁed by PCA, which can discriminate the R. hookeri, R. mi-
crantha, R. serpentina, R. tetraphylla, R. verticillata and R. vomitoria
for quality control and authentication. Present information showed
utility of accurate mass measurements which will also speed up
dereplication of MIAs.
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